A Canadian pharmaceutical company has filed a RICO suit in New Jersey state court, alleging that a hedge fund and stock analysts conspired to drive down its stock price to benefit short sellers.

Biovail Corp. of Ontario, and its subsidiary, Biovail Pharmaceuticals Inc. of Bedminster, are seeking $4.6 billion in damages in the Essex County suit, which alleges the defendants conducted a disinformation campaign to hurt its stock.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]